Vascular Disease Management

Welcome to the Classifed/Recruitment page.

For information on posting classified ads, please contact:
Tara Fields, Classified Sales Manager
(800) 237-7285, ext. 259

There are currently no listings posted.

Advertise your Job Here
For information on posting classified ads, please contact:
Tara Fields, Classified Sales Manager
(800) 237-7285, ext. 259

vdm Blogs

Aneurysms and Cancer: Which comes first in the endovascular era?

Ross Milner MD FACS

What is the best therapy when we compare current data for revascularization of the SFA?

Lawrence A. Garcia MD

When a Patient Presents with an Ulcer, Take a Careful History

Richard R. Heuser MD FACC FACP FESC FSCAI

Long-term results with bare-metal LifeStent in the SFA: Is this bad news for DES technologies?

Frank J Criado MD FACS FSVM

Two-Year Restenosis Rates are Equal for CEA and CAS, and Quite Low

Frank J Criado MD FACS FSVM

Vascular Newswire

Abbott's XIENCE PRIME and XIENCE V Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy

Wed, 05/16/12 - 9:26am
Hospital Mortality Rates for Cardiovascular Revascularization Patients Varies Significantly by State

Tue, 05/15/12 - 9:31am
Boston Scientific Announces CE Mark and European Launch of Innova Self-expanding Bare-metal Stent System

Mon, 05/14/12 - 12:07pm
Self-Expanding and Balloon-Expandable Stent Systems Perform Well in Study of Real-World Peripheral Artery Disease Patients

Fri, 05/11/12 - 11:06am

Clinical Events Calendar

EuroPCR 2012

Tue, 05/15/2012 - Fri, 05/18/2012
Paris, France
International Vein Congress (IVC) 2012

Thu, 05/31/2012 - Sun, 06/03/2012
Miami Beach, FL, United States
New Cardiovascular Horizons (NCVH)

Wed, 06/06/2012 - Sat, 06/09/2012
New Orleans, LA, United States

Poll

REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications